Invesco Ltd. Repligen Corp Transaction History

Invesco Ltd.

$503 Billion
Q1 2025

A detailed history of Invesco Ltd. transactions in Repligen Corp stock. As of the latest transaction made, Invesco Ltd. holds 1,674,477 shares of RGEN stock, worth $236 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,674,477

Previous 905,102 85.0%

Holding current value

$236 Million

Previous $130 Million 63.54%

% of portfolio

0.04%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$127.24 - $174.24 $97.9 Million - $134 Million	769,375 Added 85.0%	1,674,477 $213 Million
Q4 2024 Feb 13, 2025	SELL	$123.41 - $160.92 $18.9 Million - $24.6 Million	-152,789 Reduced 14.44%	905,102 $130 Million
Q3 2024 Nov 12, 2024	SELL	$119.79 - $167.35 $29.8 Million - $41.7 Million	-249,143 Reduced 19.06%	1,057,891 $157 Million
Q2 2024 Aug 13, 2024	BUY	$120.0 - $182.95 $7.71 Million - $11.8 Million	64,291 Added 5.17%	1,307,034 $165 Million
Q1 2024 May 14, 2024	BUY	$170.78 - $208.42 $70 Million - $85.4 Million	409,599 Added 49.16%	1,242,743 $229 Million
Q4 2023 Feb 12, 2024	BUY	$114.17 - $185.35 $14.4 Million - $23.4 Million	126,473 Added 17.9%	833,144 $150 Million
Q3 2023 Nov 13, 2023	BUY	$138.78 - $176.51 $4.24 Million - $5.4 Million	30,566 Added 4.52%	706,671 $112 Million
Q2 2023 Aug 11, 2023	SELL	$138.42 - $180.31 $98.8 Million - $129 Million	-713,881 Reduced 51.36%	676,105 $95.6 Million
Q1 2023 May 12, 2023	SELL	$154.26 - $198.1 $27.9 Million - $35.9 Million	-181,020 Reduced 11.52%	1,389,986 $234 Million
Q4 2022 Feb 13, 2023	SELL	$162.42 - $220.56 $45.5 Million - $61.8 Million	-280,265 Reduced 15.14%	1,571,006 $266 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $3.97 Million - $6.35 Million	-24,777 Reduced 1.32%	1,851,271 $346 Million
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $16.9 Million - $22.5 Million	119,891 Added 6.83%	1,876,048 $305 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $10.6 Million - $16.9 Million	65,550 Added 3.88%	1,756,157 $330 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $111 Million - $136 Million	-446,775 Reduced 20.9%	1,690,607 $448 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $39.7 Million - $66 Million	-203,661 Reduced 8.7%	2,137,382 $618 Million
Q2 2021 Aug 17, 2021	BUY	$165.87 - $220.95 $7.82 Million - $10.4 Million	47,117 Added 2.05%	2,341,043 $467 Million
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $34.2 Million - $42.9 Million	-189,570 Reduced 7.63%	2,293,926 $446 Million
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $40.2 Million - $56.1 Million	271,701 Added 12.28%	2,483,496 $476 Million
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $27.8 Million - $35.9 Million	226,733 Added 11.42%	2,211,795 $326 Million
Q2 2020 Aug 14, 2020	SELL	$94.33 - $140.48 $31.7 Million - $47.2 Million	-335,782 Reduced 14.47%	1,985,062 $245 Million
Q1 2020 May 15, 2020	SELL	$84.96 - $109.14 $1.97 Million - $2.53 Million	-23,212 Reduced 0.99%	2,320,844 $224 Million
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $15.1 Million - $19.1 Million	-204,788 Reduced 8.03%	2,344,056 $217 Million
Q3 2019 Nov 14, 2019	SELL	$76.65 - $95.51 $41.4 Million - $51.6 Million	-539,750 Reduced 17.48%	2,548,844 $195 Million
Q2 2019 Aug 14, 2019	BUY	$54.2 - $85.95 $58 Million - $91.9 Million	1,069,284 Added 52.95%	3,088,594 $265 Million
Q1 2019 May 15, 2019	SELL	$49.45 - $62.8 $4.93 Million - $6.26 Million	-99,733 Reduced 4.71%	2,019,310 $119 Million
Q4 2018 Feb 14, 2019	BUY	$48.26 - $68.88 $102 Million - $146 Million	2,119,043 New	2,119,043 $112 Million

Others Institutions Holding RGEN

# of Institutions

486

Shares Held

56.6M

Call Options Held

251K

Put Options Held

458K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.82B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account